Visiónate Peru, a financial consulting and investor education company led by financial coach and MBA Jakeline Villanueva, has announced the expansion of its services aimed at helping individuals strengthen their financial knowledge…
U.S. average retail diesel prices have climbed above $5 a gallon, a level reached only twice in U.S. history, as the U.S.-Israeli with Iran roils global fuel markets and tests the world…
Abdullah Ghaffar—widely known as iHustleBro—has officially announced the expansion of his real estate wholesaling and coaching platform, positioning himself as a rising voice in accessible wealth-building education. Operating under the brand iHustleBro,…
Lucid Group used an investor event in New York to outline a long-term plan to reach positive cash flow late this decade—anchored on a cheaper, higher-volume vehicle platform and a deeper move…
Adobe announced a major leadership transition that rattled investors, sending its shares sharply lower as markets weighed what a CEO change means for the company’s strategy in an AI-disrupted creative software landscape.…
Artificial intelligence is rapidly becoming the newest weapon in one of U.S. healthcare’s oldest conflicts: how much hospitals charge and how much insurers will actually pay. Hospitals are deploying AI to optimize…
The world’s biggest technology companies are increasingly tapping bond markets to fund an unprecedented expansion of artificial intelligence and cloud infrastructure—marking a shift for Silicon Valley firms that historically relied on huge…
House Republicans are scrambling to keep President Donald Trump’s legislative agenda on track as rising political headwinds—especially voter anxiety about the cost of living and fallout from the U.S.-Israeli war with Iran—threaten…
A wave of political controversy around Washington, D.C.’s top performing-arts venue is starting to reshape where major artists and productions choose to appear—and Baltimore is emerging as one of the beneficiaries. An…
A long-standing inequity in U.S. kidney transplantation is beginning to narrow for Black patients. The improvement follows policy changes that removed race from clinical formulas used to estimate kidney function—formulas that for…
